Prevention of cardiac autonomic neuropathy in dogs with Benfotiamine.

Source: www.benfotiamine.org

So far so good.

! That is why we pay attention to the quality of the medications.

Prevention of cardiac autonomic neuropathy in dogs with Benfotiamine.


Koltai MZ.
In Gries FA, Federlin K.

Benfotiamin in the Therapy of Polyneuropathy.
New York: Georg Thieme Verlag, 1998; 45-9.

Experimentally-induced diabetes of the dog leads to disturbances in the autonomous neurological function of the heart after approximately 3 months of continuously- observed diabetes. As signs of autonomic cardiac neuropathy, the heart rate variability and Valsalva ratio clearly fell in the untreated diabetic animals. Oral benfotiamine, administered from the sixth day after diabetes-induction, prevented or at least delayed these changes. According to the results, treatment with fat-soluble benfotiamine can play an important role in the therapy and prevention of cardiac autonomic neuropathy, apart from any effect on diabetic metabolic

Enhanced by Zemanta